Topics This Year

• Cancer Rehabilitation: Current State of the Science and Future Horizons
• Lymphedema
• Shoulder Pain and Dysfunction in Breast Cancer
• Neuromuscular Complications of Gynecologic Cancers
• New Concepts in Head and Neck Cancer   
• Dysphagia Related to Head and Neck Cancer
• Cancer-Related Cognitive Dysfunction (CRCD)
• Chemotherapy-Induced Peripheral Neuropathy (CIPN)
• Exercise Therapy for Patients Diagnosed With Cancer

Educational Objectives

Upon completion of this symposium, participants should be better able to:

• Identify the areas of rehabilitation practice and clinical interventions that have strong and moderate levels of evidence for integration into oncology care.
• Align cancer rehabilitation with survivorship care services and utilize frameworks for integration and collaboration of care.
• Evaluate clinical pathways for exercise and rehabilitative interventions for implementation into practice.
• Describe the various causes, types and stages of lymphedema. 
• Recognize the indications of lymphedema and utilize appropriate precautions in cancer patients.
• Prescribe appropriate treatment for cancer patients with lymphedema.
• Recognize the impact of breast cancer treatments such as surgery, radiation therapy and chemotherapy on shoulder anatomy and function.
• Diagnose commonly seen shoulder impairments in breast cancer patients and prescribe the most appropriate treatment options.
• Describe the neuromuscular impairments associated with gynecologic cancers and their treatment, including paraneoplastic syndromes, post-surgical complications, post-chemotherapy and post-radiation therapy.
• Utilize the multimodal approach needed to address the functional impairments caused by the neuromuscular issues associated with gynecologic cancers.
• Outline recent trends in head and neck cancer.
• Describe the technological advances in surgery for head and neck cancer patients.
• Recognize the benefits and ongoing need for rehabilitation in head and neck cancer patients.
• Outline the dysphagia treatment protocols utilized in patients receiving treatment for head and neck cancers at Miami Cancer Institute.
• Describe normal swallowing physiology and identify how each phase of swallowing can be impacted by head and neck cancer treatment.
• Recognize signs of dysphagia and its impact on quality of life using outcome measures tools.
• Describe the prevalence, phenomenology and course of cancer-related cognitive dysfunction (CRCD) in patients with breast cancer.
• Identify risk factors associated with CRCD.
• Outline the neuroanatomical correlates and pathophysiology of CRCD.
• Utilize appropriate treatment strategies for CRCD.
• Identify common chemotherapeutic agents and their pathophysiologic mechanisms associated with peripheral neuropathy.
• Describe neuropathy grading scales and assessments of neuropathy in the cancer patient, including the role for electrodiagnosis.
• Appropriately prescribe pharmacologic and non-pharmacologic interventions used to prevent and manage CIPN.
• Describe the cardiovascular consequences of anticancer therapy.
• Analyze the effects exercise can have to prevent and/or attenuate cardiovascular dysfunction in patients receiving anticancer therapy.
• Explore effects of exercise as a potential treatment for cancer.

Who Should Attend

This educational program is directed toward Neurologists, Neurosurgeons, Psychiatrists, Neuropsychologists, General Internists, Oncologists, Family Practice Physicians, Pediatricians, Physical Therapists and Assistants, Occupational Therapists and Assistants, Nurses, Social Workers, Speech-Language Pathologists, Respiratory Therapists, Pharmacists and Athletic Trainers.

Registration and Fees

BHSF Employee Rate: $99

Standard Rate: $149

Student Rate: $49

Event date: October 30, 2021

For questions, please contact Judy Kaufman, PT, Education Coordinator, Rehab at 786 385-0770